Method development, validation and bioequivalence of varenicline in human plasma by liquid chromatography tandem mass
Ayoub Al-Haj1, Mahmoud Alawi, Tawfiq Arafat
1University of Jordan, Chemistry Department, P.O. Box 13003, Amman 11942, Jordan. ajmasg150@hotmail.com
Abstract:
A method based on liquid chromatography coupled to tandem mass spectrometry was developed for quantitative determination of varenicline in human plasma. Varenicline and the internal standard (25.0ng/mL of Clarithromycin) were extracted from human plasma by liquid-liquid extraction, using methyl tertiary butyl ether as the organic solvent. The chromatographic separation was achieved using C8 column with isocratic elution using a mixture of acetonitrile:0.001M ammonium acetate (adjusted to pH 4.0) (70:30%, v/v). The method was validated over the concentration range of 0.1-10.0ng/mL by investigating specificity, sensitivity, linearity, precision, accuracy, recovery, matrix effect and stability according to United State Food and Drug Administration guideline. The validated bioanalytical method was successfully applied to evaluate bioequivalence of two commercial products of 1mg varenicline single dose.
More Related Videos
08:24Development and Standardization of an Ex Vivo Micromethod for Intracellular Quantification of Vincristine in Primary ALL Cells by LC-MS/MS
Published on: January 23, 2026
07:34Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS)
Published on: March 14, 2013
Related Concept Videos
Equivalence: In Vitro and In Vivo Bioequivalence
Measurement of Bioavailability: Pharmacodynamic Methods
Measurement of Bioavailability: Pharmacokinetic Methods
Bioequivalence studies: Biowaivers
Therapeutic Drug Monitoring: Drug Analysis Methods
Bioavailability Study Design: Single Versus Multiple Dose Studies
